Decreased Plasma Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Levels are Linked with Disease Severity in Patients with Liver Cirrhosis

Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide that has been found to reduce liver inflammation and protect liver from steatosis. We aimed to measure the level of plasma PACAP in patients with liver cirrhosis and to correlate its level with disease severity and laborato...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of peptide research and therapeutics 2021-06, Vol.27 (2), p.1229-1237
Hauptverfasser:	Yang, Lian-Ying, Hou, Ji-Ping, Han, En-Kun, Qiao, Gang, Liu, Li-Bin, Men, Xue-Bo
Format:	Artikel
Sprache:	eng
Schlagworte:	Animal Anatomy Biochemistry Biomedical and Life Sciences Biopsy Cirrhosis Fatty liver Histology Inflammation Life Sciences Liver cirrhosis Liver diseases Molecular Medicine Morphology Pharmaceutical Sciences/Technology Pharmacology/Toxicology Pituitary adenylate cyclase-activating polypeptide Plasma Polymer Sciences Polypeptides Sensitivity analysis Skeletal muscle Steatosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!